Press Releases Merck KGaA Deutsche Boerse AG

Equities

MRK

DE0006599905

Market Closed - Deutsche Boerse AG Other stock markets 15:46:14 2024-06-14 EDT			5-day change	1st Jan Change
171.6 ^EUR	+0.12%		+0.20%	+19.71%

06-11	Merck KGaA to Build EUR62 Million Facility for Life Science Business	MT
06-07	Health Care Up as Defensive Rotation Continues - Health Care Roundup	DJ

Press Releases

Unlock all the news: Be the first to know and act before the market!

100% Free Registration

Merck : Q1 24 Financial Statement	05-16	PU
Merck : Q1 24 Earnings Presentation	05-16	PU
Merck : Q1 24 Quarterly statement	05-14	PU
Caris Life Sciences Announces Partnership with Merck KGaA, Darmstadt, Germany to Discover Novel Cancer Targets and Accelerate First-In-Class Antibody Drug Conjugate Development	04-05	AQ
Merck's Corporate Venture M Ventures Arm Backs Nucleai to Advance Its First-in-class Spatial AI Biomarker in Active Clinical Enrollment	04-04	AQ
Merck : Prospectus - C-029771	03-28	PU
DD: Merck KGaA: Dr. Matthias Heinzel, buy	03-27	EQ
DD: Merck KGaA: Peter Guenter, buy	03-27	EQ
Merck KGaA, Darmstadt, Germany, Invests More than EUR 300 Million in New Life Science Production Site in Korea	03-21	AQ
AFR: Merck KGaA: Preliminary announcement of the publication of financial reports according to Articles 114, 115, 117 of the WpHG [the German Securities Act]	01-25	EQ
AFR: Merck KGaA: Preliminary announcement of the publication of quarterly reports and quarterly/interim statements	01-25	EQ
Biocytogen Launches RenBiologics, a Sub-Brand Focused on Out-Licensing Fully Human Antibodies for Therapeutic Development	01-24	AQ
Inspirna Partners with Merck KGaA, Darmstadt, Germany, to Accelerate Global Development of Ompenaclid	01-05	AQ
Merck KGaA: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution	12-13	EQ
Merck KGaA: Phase III trial results for evobrutinib in relapsing multiple sclerosis did not meet primary endpoint of reducing annualized relapse rates (ARR) compared to oral teriflunomide	12-05	EQ
Merck KGaA: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution	11-27	EQ
Merck KGaA: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution	11-24	EQ
Veeva European Commercial Summit Gathers Life Sciences Industry Leading the Next Generation of Commercial Excellence	11-23	AQ
Merck KGaA: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution	11-22	EQ
Merck KGaA: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution	11-21	EQ

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Headlines

MERCK : A lower starting point for future growth

May 27, 2024 at 03:36 am

Merck KGaA : A European big pharma with positive momentum

January 20, 2023 at 05:51 am